In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

The primary endpoint was restoration of catheter patency, and the secondary endpoint was the occurrence of bleeding episodes within 24 hours of alteplase administration. Catheter removal due to ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

Background and Issue: The rural, critical access emergency department (ED) team was not consistently meeting the door-to-needle goal of 45 minutes for alteplase administration to acute stroke patients ...

Alteplase is also sold by Boehringer in the ... expensive option" of the available thrombolytics when factors like administration costs, dosages, price per dose, and commercial arrangements ...

Pharmacologic thrombolysis takes center stage in high-risk cases, with alteplase (tPA) considered the standard ... is evaluating how any device approved by the U.S. Food and Drug Administration ...

Alteplase improves stroke recovery by over 50% when given up to 24 hours after symptom onset, offering hope for patients with ...

Read more › Aid to South Africa: Mr. Trump ordered that all aid to South Africa be halted and said his administration would prioritize the resettling of white “Afrikaner refugees” into the ...